U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea
· Delayed Price · Currency is KRW 20,400
-50 (-0.24%)
At close: Apr 27, 2026
538.50% (1Y)
| Market Cap | 310.52B |
| Revenue (ttm) | 25.59B |
| Net Income (ttm) | -1.64B |
| Shares Out | 15.93M |
| EPS (ttm) | -141.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (0.49%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 335,703 |
| Average Volume | 630,729 |
| Open | 19,640 |
| Previous Close | 20,450 |
| Day's Range | 19,240 - 20,800 |
| 52-Week Range | 2,900 - 32,800 |
| Beta | 1.89 |
| RSI | 52.96 |
| Earnings Date | n/a |